Beverly, Mass. – September 11, 2026 -- Axcelis Technologies (Nasdaq: ACLS) will invest $35 million to build a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea, with production slated to begin in the second half of 2028.